The FDA has asked for another well-controlled trial to establish the efficacy of reproxalap in dry eye disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback